Unlocking delays: revealing barriers to early diagnosis of childhood central nervous system tumors in an upper-middle-income country.

Abstract

Childhood central nervous system (CNS) tumors tend to have a longer time interval until diagnosis than other pediatric malignancies. The aim is to describe the time to diagnosis among Brazilian pediatric patients treated at a tertiary center and explore associated factors. Cross-sectional study; application of questionnaires to parents of children with CNS tumors during outpatient visit or inpatient care. One hundred parents participated between August and November 2023. The median age of the children at diagnosis was 7.2years old. Low-grade glioma (LGG) was the most common tumor type (37%), followed by medulloblastoma (24%). The most frequent symptoms were morning and/or persistent vomiting and headache. The mean prediagnostic symptomatic interval (PSI) was 150days. The mean parental interval was shorter than the medical (58.1days vs 92.8days). LGGs and tumors located in the central area had longer intervals to diagnosis than other tumors (296 vs 54days) (p = 0.005) and (206 vs 155days) (p = 0.007), respectively. Despite 81% of the patients undergoing pediatric routine follow-up, 87% of them had been diagnosed at an emergency department. Children attended by the same physician had a shorter mean interval (18.2 vs 88.3days) than those assisted by different professionals (p = 0.015). The mean time for referral to our specialized center was 23days. This study is a crucial step in recognizing barriers to early diagnosis of CNS tumors in a middle-income country as low awareness of signs/symptoms by parents and health professionals, aiming to provide opportunities for intervention strategies to reduce the time to diagnosis.